Stock Markets February 17, 2026

Theon lifts guidance after 2025 beats; strong margins and backlog underpin 2026 outlook

Greek defense optics maker posts higher-than-expected 2025 results, reports robust backlog and tightens working capital targets

By Sofia Navarro
Theon lifts guidance after 2025 beats; strong margins and backlog underpin 2026 outlook

Theon shares climbed more than 3% on Tuesday after the company released preliminary 2025 results that topped analyst projections across key metrics. The firm reported a €1.4 billion soft order backlog, sales of €444 million, an adjusted EBIT margin of 26.2%, and year-end net cash of €126.9 million. Management expects 2026 revenues of €570-600 million and highlighted continued margin tailwinds from a favorable product mix.

Key Points

  • Order backlog of €1.4 billion beats estimates by €100 million, with further large platform deals expected in 2026 - impacts defense contracting and procurement.
  • 2025 sales rose 26% to €444 million; 2026 guidance of €570-600 million implies organic growth over 15% - impacts defense manufacturing and market expectations.
  • Adjusted EBIT margin of 26.2% exceeded forecasts, helped by higher-margin thermal imaging products - impacts optics manufacturing and profitability metrics.

Overview

Theon, a Greek manufacturer of defense optics, saw its stock rise by over 3% on Tuesday following preliminary results for 2025 that outpaced analyst expectations on several fronts. Management detailed a larger-than-expected order backlog, healthy top-line growth, and improved profitability metrics, while setting a 2026 revenue range that implies continued organic expansion.

Order book and 2026 pipeline

The company reported a soft order backlog of €1.4 billion, exceeding analyst estimates by €100 million. Management signaled that additional sizeable contracts are expected to close in 2026, with the platforms segment specifically cited as an area where further large deals are anticipated.

Revenue and outlook

Sales for 2025 rose 26% year-over-year to €444 million, coming in roughly 2-3% ahead of forecasts. For 2026, Theon provided guidance for revenue in the range of €570-600 million. That range aligns with analyst consensus near €600 million and implies organic growth in excess of 15% versus the 2025 revenue figure.

Profitability and product mix

Adjusted EBIT margin for 2025 reached 26.2%, outperforming the 25% analysts had expected by about 120 basis points. Management noted the product mix as a contributor to margin strength, observing that thermal imaging products generally deliver higher margins than night vision systems - a dynamic that supports expectations for healthy 2026 margins.

Cash position, acquisitions and cash flow

Year-end net cash stood at €126.9 million. That amount includes proceeds from a December €150 million rights issue but does not account for the subsequent €69 million acquisition of Kappa. The results imply that free cash flow beat expectations by approximately €19 million.

Working capital and efficiency targets

Theon reported improved working capital efficiency, with net working capital as a percentage of sales falling to 41% from 44.2%. Management has set a mid-term objective of reducing that ratio to 35%.


Key points

  • Order backlog of €1.4 billion surpasses estimates by €100 million, with more large platform deals expected in 2026 - sectors impacted: defense contracting and military platforms.
  • 2025 sales grew 26% to €444 million and 2026 revenue guidance of €570-600 million implies organic growth above 15% - sectors impacted: defense manufacturing and capital markets.
  • Adjusted EBIT margin of 26.2% benefits from a favorable shift toward higher-margin thermal imaging products - sectors impacted: defense optics and technology manufacturing.

Risks and uncertainties

  • Future revenue depends in part on additional large deals anticipated in 2026; there is uncertainty over the timing and completion of those contracts - this affects the defense procurement and contractor sectors.
  • Net cash reported at year-end excludes the €69 million Kappa acquisition, which will change the companys post-deal liquidity position; that alters balance-sheet resilience and could influence financing flexibility in capital markets.
  • The firm aims to reduce net working capital to 35% of sales in the mid-term; failure to hit that target would affect working capital efficiency and free cash flow generation, with implications for corporate finance and investor returns.

Risks

  • Reliance on additional large 2026 deals creates uncertainty over revenue realization and timing - affects defense procurement and contract execution.
  • Year-end net cash excludes the €69 million Kappa acquisition, which will reduce post-acquisition liquidity and alter balance-sheet metrics - affects corporate finance and investor assessment.
  • Achieving the mid-term net working capital target of 35% of sales is uncertain; missing the target could constrain free cash flow improvement and operational efficiency.

More from Stock Markets

Indigenous Occupation Halts Operations at Cargill’s Santarem Terminal Feb 21, 2026 Market Turbulence Reinforces Case for Broader Diversification Feb 21, 2026 NYSE Holdings UK Ltd launches unified trading platform to streamline market access Feb 21, 2026 Earnings Drive Weekly Winners and Losers as Buyout Headlines Lift Masimo Feb 21, 2026 Barclays Sees 'Physical AI' Scaling to Hundreds of Billions by 2035 Feb 21, 2026